down arrow

Sr.Rayala.Hypo

  • Market Cap: Micro Cap
  • Industry: Chemicals
  • ISIN: INE917H01012
  • NSEID: SRHHYPOLTD
  • BSEID: 532842
INR
502.00
9 (1.83%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 14.14 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

14.14 k (12.14%) Volume

Shareholding (Dec 2024)

FII

0.08%

Held by 4 FIIs

DII

0.03%

Held by 0 DIIs

Promoter

61.84%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of -4.87% over the last 5 years

 
2

The company has declared Negative results for the last 7 consecutive quarters

3

Stock is technically in a Bearish range

4

Despite the size of the company, domestic mutual funds hold only 0.02% of the company

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Chemicals

stock-summary
Market cap

INR 862 Cr (Micro Cap)

stock-summary
P/E

10.00

stock-summary
Industry P/E

41

stock-summary
Dividend Yield

0.58%

stock-summary
Debt Equity

-0.41

stock-summary
Return on Equity

10.07%

stock-summary
Price to Book

0.97

Revenue and Profits (1 Year):
Net Sales:
138 Cr
(Quarterly Results - Dec 2024)
Net Profit:
22 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.58%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-43.84%
0%
-43.84%
1 Year
-12.17%
0.54%
-11.63%
2 Years
8.27%
1.38%
9.65%
3 Years
10.51%
2.83%
13.34%
4 Years
94.54%
4.56%
99.1%
5 Years
425.93%
17.20%
443.13%

Latest dividend: 3 per share ex-dividend date: Sep-12-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.87%
EBIT Growth (5y)
5.18%
EBIT to Interest (avg)
40.63
Debt to EBITDA (avg)
0.28
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.69
Tax Ratio
27.68%
Dividend Payout Ratio
6.52%
Pledged Shares
0
Institutional Holding
0.11%
ROCE (avg)
23.49%
ROE (avg)
14.39%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
41
Price to Book Value
0.97
EV to EBIT
5.24
EV to EBITDA
4.82
EV to Capital Employed
0.95
EV to Sales
0.76
PEG Ratio
NA
Dividend Yield
0.58%
ROCE (Latest)
18.35%
ROE (Latest)
10.07%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 3 Schemes (0.01%)

FIIs

Held by 4 FIIs (0.08%)

Promoter with highest holding

Gowri Gopal Hospitals Private Limited (21.8%)

Highest Public shareholder

None

Individual Investors Holdings

26.26%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -18.66% vs 0.95% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -14.78% vs 35.88% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "138.47",
          "val2": "170.24",
          "chgp": "-18.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.80",
          "val2": "28.94",
          "chgp": "-31.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.37",
          "val2": "0.32",
          "chgp": "15.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "21.56",
          "val2": "25.30",
          "chgp": "-14.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.30%",
          "val2": "17.00%",
          "chgp": "-2.70%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -30.32% vs -46.79% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 2.64% vs -28.24% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "338.87",
          "val2": "486.32",
          "chgp": "-30.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "54.61",
          "val2": "61.39",
          "chgp": "-11.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.92",
          "val2": "1.28",
          "chgp": "-28.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "43.92",
          "val2": "42.79",
          "chgp": "2.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.12%",
          "val2": "12.62%",
          "chgp": "3.50%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -31.89% vs -42.31% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 10.20% vs -28.54% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "477.34",
          "val2": "700.84",
          "chgp": "-31.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "74.41",
          "val2": "83.56",
          "chgp": "-10.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.29",
          "val2": "1.90",
          "chgp": "-32.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-5.87",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "65.48",
          "val2": "59.42",
          "chgp": "10.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.59%",
          "val2": "11.92%",
          "chgp": "3.67%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -47.52% vs 30.21% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -48.80% vs 50.08% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "866.01",
          "val2": "1,650.12",
          "chgp": "-47.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "110.57",
          "val2": "177.69",
          "chgp": "-37.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.98",
          "val2": "2.03",
          "chgp": "96.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-10.86",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "78.97",
          "val2": "154.25",
          "chgp": "-48.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.77%",
          "val2": "10.77%",
          "chgp": "2.00%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
138.47
170.24
-18.66%
Operating Profit (PBDIT) excl Other Income
19.80
28.94
-31.58%
Interest
0.37
0.32
15.62%
Exceptional Items
0.00
0.00
Consolidate Net Profit
21.56
25.30
-14.78%
Operating Profit Margin (Excl OI)
14.30%
17.00%
-2.70%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -18.66% vs 0.95% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -14.78% vs 35.88% in Sep 2024

Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
338.87
486.32
-30.32%
Operating Profit (PBDIT) excl Other Income
54.61
61.39
-11.04%
Interest
0.92
1.28
-28.12%
Exceptional Items
0.00
0.00
Consolidate Net Profit
43.92
42.79
2.64%
Operating Profit Margin (Excl OI)
16.12%
12.62%
3.50%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -30.32% vs -46.79% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 2.64% vs -28.24% in Sep 2023

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
477.34
700.84
-31.89%
Operating Profit (PBDIT) excl Other Income
74.41
83.56
-10.95%
Interest
1.29
1.90
-32.11%
Exceptional Items
0.00
-5.87
100.00%
Consolidate Net Profit
65.48
59.42
10.20%
Operating Profit Margin (Excl OI)
15.59%
11.92%
3.67%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -31.89% vs -42.31% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 10.20% vs -28.54% in Dec 2023

Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
866.01
1,650.12
-47.52%
Operating Profit (PBDIT) excl Other Income
110.57
177.69
-37.77%
Interest
3.98
2.03
96.06%
Exceptional Items
-10.86
0.00
Consolidate Net Profit
78.97
154.25
-48.80%
Operating Profit Margin (Excl OI)
12.77%
10.77%
2.00%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -47.52% vs 30.21% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -48.80% vs 50.08% in Mar 2023

stock-summaryCompany CV
About Sree Rayalaseema Hi-Strength Hypo Ltd stock-summary
stock-summary
Sree Rayalaseema Hi-Strength Hypo Ltd
Micro Cap
Chemicals
Sree Rayalaseema Hi-Strength Hypo Ltd was incorporated in March, 2005. The Company is the leading producer of Calcium Hypo Chloride, Stable Bleaching Powder, Sulphuric Acid and other chemicals. Sree Rayalaseema Hi-Strength Hypo, the torch bearer of the conglomerate, is the only Indian manufacturer of Calcium Hypochlorite, and one of the very few in the world.
Company Coordinates stock-summary
Company Details
Gondiparla , Kurnool Andhra Pradesh : 518004
stock-summary
Tel: 91-40-23313842
stock-summary
Registrar Details
Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad